Vermillion, Beckman Coulter Lead Strong December for GWDN Index | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The stocks of Vermillion and Beckman Coulter rose sharply during the month of December, as the GenomeWeb Daily News Index posted a strong month to end the year.

Overall, the Index was up more than 10 percent for the month, while the broader stock market also saw significant gains. The Dow Jones Industrial average rose just over 5 percent, the Nasdaq jumped a little more than 6 percent, and the Nasdaq Biotech Index was up nearly 7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.